While there are some limitations and issues that need to be further investigated, these results suggest that longitudinal PET imaging of VMAT2 using [18F]FP-(+)-DTBZ has potential for non-invasively and quantitatively measuring BCM in patients with T1D. Here, SLC18A2 is linked to type 1 diabetes mellitus.